Usability of Cognitive Improvement Software in Cognitively Impaired Patients: Pilot Study

NCT ID: NCT05634161

Last Updated: 2024-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-21

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Usability study of software application that provide digitized cognitive intervention therapy for cognitively impaired patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cognitive Improvement software

Usability assessment of cognitive improvement software

Cognitive improvement software

Intervention Type OTHER

Cognitive improvement software

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive improvement software

Cognitive improvement software

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and Female patients, 55\~85 years
* Adequate vision, hearing and speaking for neuropsychological testing
* No difficulty in using mobile application using smartphone
* Patients with subjective memory complaints, confirmed by informants
* Cognitive impairment of SD 1 or greater from the age-adjusted normal range in Memory domain in CERAD-NP battery
* Global CDR 0.5 \~ 1
* Korean speaker
* Have an identified trial partner
* All subjects signed written consent

Exclusion Criteria

* Those unable to provide consent
* History of transient ischemic attack, stroke, brain tumor
* History of diagnosis of major depression
* Symptoms that may interfere with the subject's testing procedure
* Cerebral hemorrhage
* Central nervous system infections
* Prohibited concomitant medication
* Known or suspected history of drug or alcohol abuse
Minimum Eligible Age

55 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Boramae Hospital

OTHER

Sponsor Role collaborator

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jun Young Lee

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jun-Young Lee, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Psychiatry, Seoul National University College of Medicine, Department of Psychiatry, SMG-SNU Boramae Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul Metropolitan Government Seoul National University Boramae Medical Center

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-2022-48

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.